Blossom Biosciences
Latest round
- Series A
Last raised
- Jun 2021
Total raised
- $72M
Investors
- 2
About Blossom Biosciences
Based in Beijing, China and established in 2021, Bosheng Pharmaceutical is a medical company that focuses on drug development. The company was co-founded by Osprey Asset Management and Hansen Pharmaceutical Group. The company is committed to bringing potential breakthrough therapeutics to more patients in China, and Dr. Andrew Phillips, Managing Director of Fishhawk Capital Management and former CEO of C4 Therapeutics, Inc. is now acting CEO of the company. The company focuses on the development of therapeutic drugs and offers a full range of molecular and cell biology research methods, including mammalian cell culture, transfection, cell viability assays, IC50/EC50 studies, apoptosis, molecular cloning, WesternBlot and ELISA assays.
Who invested in Blossom Biosciences
2 investors across 1 round
See all investors in Blossom Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 17, 2021
Amount
$72M
Investors
Questions about Blossom Biosciences
Who invested in Blossom Biosciences?
Blossom Biosciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Blossom Biosciences raised?
Blossom Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Blossom Biosciences last raise money?
Blossom Biosciences's most recent round on record is a Series A, in Jun 2021.
What does Blossom Biosciences do?
Based in Beijing, China and established in 2021, Bosheng Pharmaceutical is a medical company that focuses on drug development.
Where is Blossom Biosciences headquartered?
Blossom Biosciences is headquartered in Beijing, China.
Which VCs invest in companies like Blossom Biosciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Blossom Biosciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Blossom Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.